CLINICAL_TRIALS
trial_result
· 2018-05-09
Clinical Trial Update: The Size of Pelvic Hematoma Can be a Predictive Factor for Angioembolization
Summary
A completed clinical trial suggests that the size of a pelvic hematoma may predict the need for pelvic angioembolization in patients with pelvic fractures.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Asan Medical Center | Conditions: Multiple Pelvic Fractures | Status: COMPLETED